MALAT1 and non-small cell lung carcinoma: In addition, in the serum of NSCLC patients with good immunotherapy outcomes, exosomes were isolated, and MALAT1, AGAP2-AS1, ATB, TCF7, FOXD2-AS1, HOXA11-AS, PCAF1, and BVAR4 were proven to be highly expressed, which indicates the potential of serum exosomal lncRNAs as biomarkers for predicting response [177].